Drug Type Small molecule drug |
Synonyms Dibucaine hydrochloride (JP17/USP), Heavy Solution Nupercaine, Nupercaine hydrochloride + [1] |
Target |
Mechanism Nav1.5 blockers(Sodium channel protein type V alpha subunit blockers), Nav1.8 blockers(Sodium channel protein type X alpha subunit blockers) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseWithdrawn |
First Approval Date- |
Regulation- |
Molecular FormulaC20H30ClN3O2 |
InChIKeyIVHBBMHQKZBJEU-UHFFFAOYSA-N |
CAS Registry61-12-1 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D02220 | Dibucaine Hydrochloride | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Anesthesia | US | - |